Tier 2 · Liquid 3000

Tarsus Pharmaceuticals, Inc.

TARS · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$90.78
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001819790
Liquidity rank
#647
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$451.36M2025-12-310001819790-26-000019
Annual diluted EPS-1.592025-12-310001819790-26-000019
Quarterly revenue$173.91M2026-06-300001819790-26-000064
Quarterly diluted EPS-0.432026-06-300001819790-26-000064

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.556Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-09-21 through 2026-09-21.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance